Hypertensive Emergency Management

Initial Assessment and Medication Selection

The American Heart Association recommends confirming the presence of acute target organ damage to distinguish true hypertensive emergency from hypertensive urgency, with examples including neurologic, cardiac, vascular, renal, and obstetric damage 1, 2
The American College of Cardiology suggests that nicardipine is the preferred initial agent for most hypertensive emergencies due to its predictable titration, maintenance of cerebral blood flow, and lack of reflex tachycardia 1, 2
Labetalol is an excellent alternative, particularly for patients with tachycardia or when dual alpha/beta blockade is beneficial, with dosing starting at 0.25-0.5 mg/kg IV bolus (maximum 20 mg) every 10 minutes 1, 2

The American Heart Association recommends reducing mean arterial pressure by 20-25% (or SBP by no more than 25%) in the first hour, with further reductions to 160/100 mmHg over the next 2-6 hours 1, 2, 3
For compelling conditions such as aortic dissection, severe preeclampsia/eclampsia, and acute coronary syndrome, more aggressive targets are recommended, including SBP <120 mmHg within 20 minutes for aortic dissection 1, 2, 3

For acute pulmonary edema/heart failure, nitroglycerin IV is preferred, with dosing starting at 5-10 mcg/min and titrating by 5-10 mcg/min every 5-10 minutes 2, 3
For eclampsia/preeclampsia, hydralazine, labetalol, or nicardipine are recommended, with absolute contraindications including ACE inhibitors, ARBs, and nitroprusside 1, 2

All hypertensive emergencies require ICU admission, continuous arterial line BP monitoring, serial assessment of target organ function, and parenteral therapy with titratable agents, according to the American College of Cardiology (Class I recommendation, Level B-NR) 1, 2, 3

Short-acting nifedipine, sodium nitroprusside as first-line, hydralazine as first-line, and oral medications are not recommended for hypertensive emergencies due to unpredictable responses, toxicity risks, and delayed onset of action 1, 2

After 24-48 hours of stability, transition to an oral antihypertensive regimen, screen for secondary hypertension causes, address medication non-compliance, and arrange frequent follow-up until target BP is reached, as recommended by the American Heart Association 2, 3